See All Slides - tctmd.com

Slides

Presentation TCT 2013

Mitral Valve Replacement in Functional MR: Indications, Frequency, Outcomes, and Perspectives as When This Is an Appropriate Alternative to Repair

Presenter: Eugene Blackstone

October 28, 2013

Presentation TCT 2013

Prognostic Implications of Quantitative Ischemia in Stable Ischemic Heart Disease: Lessons from SPECT, PET, and FFR

Presenter: Leslee Shaw

October 28, 2013

Presentation TCT 2013

Stop the Debate! Selective Use of BMS Is Rational and Cost-Effective

Presenter: David Cohen

October 28, 2013

Presentation TCT 2013

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

Presenter: George Dangas

October 28, 2013

Presentation TCT 2013

Nursing Leadership Development: Retaining Your Strongest Players

Presenter: Tim Wages

October 28, 2013

Presentation TCT 2013

Case Examples(6)

Presenter: Ted Feldman

October 28, 2013

Presentation TCT 2013

CTA Detection of Coronary Calcification: Prognosis and Pathophysiology

Presenter: Stephan Achenbach

October 28, 2013

Presentation TCT 2013

Institutional Benefits of a CTO Program

Presenter: James Hermiller Jr

October 28, 2013

Presentation TCT 2013

Essential CTO Histopathology: Differences Pre- and Post- Bypass CTO, and Implications for Intervention

Presenter: Michael Joner

October 28, 2013

Presentation TCT 2013

Editorial Comment: LAA Exclusion: Anatomical Considerations, Device Selection and Outcomes

Presenter: Juan Granada

October 28, 2013

Advertisement

Slides

Mitral Valve Replacement in Functional MR: Indications, Frequency, Outcomes, and Perspectives as When This Is an Appropriate Alternative to Repair

Prognostic Implications of Quantitative Ischemia in Stable Ischemic Heart Disease: Lessons from SPECT, PET, and FFR

Stop the Debate! Selective Use of BMS Is Rational and Cost-Effective

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

Nursing Leadership Development: Retaining Your Strongest Players

Case Examples(6)

CTA Detection of Coronary Calcification: Prognosis and Pathophysiology

Institutional Benefits of a CTO Program

Essential CTO Histopathology: Differences Pre- and Post- Bypass CTO, and Implications for Intervention

Editorial Comment: LAA Exclusion: Anatomical Considerations, Device Selection and Outcomes

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content